chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I received my Pfizer booster for COVID-19 on 11/29/2021. On about 1/16/2022, I developed an itchy, sore throat. Not only that, but I had been dealing with fatigue for a while. I took some Tylenol, but the symptoms didn't go away. The symptoms continued on 1/17/2022, plus I had a little bit of a cough. I decided to take a BinaxNOW home antigen test on 1/18/2022, and I got a positive result. I isolated in my room. I was fatigued, so I spent quite a bit of time sleeping. Whenever I had to talk with people, I always did it outdoors and wearing an N95 mask. I tested every day after I got the positive result, and I didn't get a negative result until 1/24/2022. Even though I had tested negative, I still felt tired. The fatigue lasted possibly for a month after I tested negative.
At midnight on03/27/2021 a ringing started in my right ear. I was unable to sleep the whole night so I can recall the ringing (sounded like someone was ringing a small Christmas  bell in my ear) it was intermittent, starting and stopping the whole night. The next day 03/27/2021 it became more and more constant.  Today is 03/28/2021 and it?s constant now and in both ears
The vial was initially stored in the refrigerator was 24-Jan-2022 and administered on 10-Mar-2022; Pharmacy gave Moderna COVID-19 vaccine past its beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Pharmacy gave Moderna COVID-19 vaccine past its beyond use date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator was 24-Jan-2022 and administered on 10-Mar-2022) in a 47-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 030H21B) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 10-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Pharmacy gave Moderna COVID-19 vaccine past its beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator was 24-Jan-2022 and administered on 10-Mar-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Pharmacy gave Moderna COVID-19 vaccine past its beyond use date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator was 24-Jan-2022 and administered on 10-Mar-2022) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  The pharmacist wrote an expiration date of 24-Mar-2022 on the Moderna COVID-19 vaccine instead of 24-Feb-2022. The Moderna COVID-19 vaccine was transferred from the freezer to the refrigerator on 24-Jan-2022. The vial did not undergo any temperature excursions. The reporter did not know which dose the patient was received. The reporter did not have any other adverse events or side effects to report for the patient.  No treatment information was provided by the reporter.
About two days after 1st does, left breast started to hurt felt quarter size lump in breast then felt other lumps in breast and with striking pain. Still have swollen glands After 2 dose
After the first  dose, my Mother suddenly lost the sight in her right eye. We went to Hospital where they told us she had a stroke in her eye. Then after the second dose on September 22 she had a serious medical emergency where I had to perform CPR to bring her back to life. When she was rushed to the hospital they had no explanation for the incident. She was thoroughly checked and they couldn't explain it. She wore a heart monitor for a month and that was normal. After the booster on 10/21/21, she has had no energy, severe chills and shaking, extreme  nausea, and extreme fatigue with no fever.. She has had 3 COVID tests which were negative, and extreme thirst.
After vaccination mother notice redness in the Right Thigh few hours later; next day area was larger and today area is even bigger measure at 65/70mm, currently being seen by PCM and prescribed Zyrtec and doctor marked it and said to come back on Monday if area gets larger.
ITCHING AT SITE, ENTIRE BODY, LEGS/THIGHS SWELLED UP, UNBEARABLE, BUT AIRWAY OKAY
bacterial pneumonia; felt a little ill; felt tired the next day; had a sore arm for a day; This spontaneous case was reported by a consumer and describes the occurrence of PNEUMONIA BACTERIAL (bacterial pneumonia) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 020A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In May 2021, the patient experienced PNEUMONIA BACTERIAL (bacterial pneumonia) (seriousness criteria hospitalization and medically significant). On an unknown date, the patient experienced VACCINATION COMPLICATION (felt a little ill), FATIGUE (felt tired the next day) and VACCINATION SITE PAIN (had a sore arm for a day). The patient was hospitalized from sometime in May 2021 to sometime in May 2021 due to PNEUMONIA BACTERIAL. At the time of the report, PNEUMONIA BACTERIAL (bacterial pneumonia), VACCINATION COMPLICATION (felt a little ill) and FATIGUE (felt tired the next day) outcome was unknown and VACCINATION SITE PAIN (had a sore arm for a day) had resolved.            No relevant concomitant medications were reported. No treatment information was provided. Patient was hospitalized for 4.5 days around the end of May for bacterial pneumonia with no other side effects or symptoms.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.  Further information is not expected due to decline on follow up.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.  Further information is not expected due to decline on follow up.
a fib with RVR. Patient also had viral like symptoms day after the vaccine (fatigue, chills)
Nurse calling to report VARIVAX was administered to patient while it had a temperature excursion. Exact date of administration not provided. Patient is asymptomatic. No additional AE. No PQC. Names of vaccines involved (including lot/exp) VARIVAX W02; Patient is asymptomatic. No additional AE.; This spontaneous report was received from nurse, referring to patient of unknown gender and age.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On an unknown date, the patient was vaccinated with 1 dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, (lot #W025274 has been verified to be a valid lot, expiration date: 10-AUG-2024) for prophylaxis (strength, dose regimen, and route of administration were not provided), while it had a temperature excursion of 24.4 Fahrenheit grades for 5 hours 51 minutes. There was not previous temperature excursion. The patient was asymptomatic, no additional adverse event was reported.
About 9-10 hours after my vaccination I started to run a fever. Around 1:30am  the day after my fever reached 101.5 (taken orally) but responded to Tylenol. The next day I ran a low-grade fever for the whole day. On the Sunday after my vaccine (on Friday morning) I felt much better. Fever gone.
Real Puffy Face, Excessive Sweating, Severe Fatigue, Extreme Agitation, Fluctuating Fever, Nausea, Debilitating Headaches, afraid.
Headache, body aches, chills, fatigue, dizziness, confusion, extremity tingling in first 24 hours. At 26 hours post injection, severe left axillary lymphadenopathy noted with axillary pain.
Shot in left arm. Glands on left side of body badly swollen. (at base of neck, groin of left leg)
Patient complained of pain in left arm, fatigue, swollen lymph nodes and difficulty sleeping. He lost 1 duty day and given pain medicine.
Swelling , redness, hard tissue around the injection site- present within 1 hour of injection. Body aches and chills- 25 hours after injection
Initial information received on 11-Jul-2018 regarding an unsolicited valid non-serious case received from other health professional. This case involves a 12 months old female patient who received ACT-HIB with expired 0.4 percent Nacl diluent/ no reportable adverse events. The patients past medical history and family history were not provided. The patient did not receive any concomitant medication. It was an actual medication error due to expired product administered. On 11-Jul-2018, the patient received a 0.5ml dose of suspect HIB (PRP/T) VACCINE lot U5859AB via intramuscular route in right leg. It was reported that patient received ActHIB with expired 0.4 percent NaCl diluent today/ no reportable adverse events. Expiration date on diluent read was 01 Jul 2018. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. List of documents held by sender- none.
Low grade temp, irritability, decreased intake, high pitched cry, started day following vaccine. Symptoms lasted 3 days, going on day 4.
6-18-15 Client reports "not feeling well" 6/17, evening, with "slight swelling of my tongue". States 6/18, AM, symptoms worse with "more tongue swelling and a tightness in chest". Was being taken to Emergency Room when she called.
21 yo M presented with near syncope, pale, diaphoretic, difficulty breathing. EMS eval. BP 108/70, HR 165, 4-lead. Pt care transferred to responding EMS unit, Pt transported to local hospital emergency room for continued treatment.
pt c/o severe lower back pain and thigh pain(left side of body), left breast pain, extremely tired and weak, difficulty walking, decrease balance
Redness, warmth, swelling left deltoid per parent started several hours after immunization on 10/30/07 now slightly improved
Pt recv vax on unspecified date; on unspecified date pt exp rxn of injection site of swelling,redness,warmth &pain; pt tx=antihistamine &warm compresses.
Onset of severe nausea followed by difficulty breathing, uncontrollable incessant dry heaving and coughing, spasms, full body shaking, full body tremors, inability to speak, seizure like reaction, dizziness,  tingling in tongue,
Patient reported arm pain, diarrhea, nausea, and headache. Pt reported that she has had chronic headache due to her brain aneurysm but it has gotten worse after the vaccine. Symptoms started since yesterday after receiving the vaccine and has not subsided since today. Advised patient that these are the expected signs/symptoms of vaccine. Will subside in couple of days.
The patient was told that because it had been over 90 days that the first vaccine was not valid, therefore the patient received 3 doses of Pfizer.
a severe ache & throbbing pain in area of vax;a severe throbbing pain in area of vax when moved the arm or tried to pick up even the lightest object;unable to use of lift the arm at all;unable to sleep @ noc;irritability; jaw pain
Pt recvd 3 doses of Hep B vax 1NOV90, 4DEC90, & 3JUN91 & 16AUG91 it was determined that titer was neg; booster dose was given 20AUG91 & 21OCT91 titer was neg;
Symptoms began on Wednesday; nasal congestion and sore throat. It continued into Thursday. I did two at home tests and they were both positive. I contacted my doctor on Friday. They arranged for an infusion on Saturday, July 30th. Since I take amiodarone I was advised not to take PAXLOVID. I had the infusion and as of today my symptoms are much better. No sore throat and a bit of a runny nose.
Headache; fatigue; muscle and extreme joint pain; muscle and extreme joint pain; This is a spontaneous report received from a contactable other health care professional (HCP). A 21-years-old non pregnant female patient received bnt162b2 (BNT162B2, Solution for injection ), via an unspecified route of administration, administered on arm left on 26Jan2021 10:30 (at the age of 21-year-old) as single dose for covid-19 immunization. Medical history included fibromyalgia and postural orthostatic tachycardia syndrome (POTS). The patient had no covid prior to vaccination and no covid tested post vaccination. Concomitant medication included ibuprofen and fluoxetine hydrochloride (PROZAC). On 27Jan2021 03:00, the patient experienced headache, fatigue and muscle and extreme joint pain. The patient did not received any treatment for the event. The outcome of the events were recovering.   Information on the lot/batch number has been requested.  Follow-up (16Apr2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Hives developed on his face at 1PM the same day as flumist was given. He continued to have hives on his face, back, arms, buttocks, and hands until 10/07/2009.  The last hives developed around 5:30 PM on 10/07/2009.  The hives were treated with Benadryl after speaking with the pediatricians office.  He developed a fever of 101 the morning of 10/07/2009.  We took him to the pediatrician office on Thursday.
Ten days after receiving DTaP, Hep A, Hib, MMR, PREVNAR, Varicella presented to office w/ 2d hx temp to 103, decreased appetite, diffuse erythematous papular rash.
Sleepy; Just weak in general; Tired; This is a spontaneous report from a contactable consumer or other non hcp (Patient).  A patient of unspecified age and gender received second dose of bnt162b2 (BNT162B2, PFIZER-BIOTECH COVID-19 VACCINE, solution for injection Batch/Lot number was not reported), via an unspecified route of administration on 25Jun2021 as single dose for covid-19 immunization. No Medical history and no medications were not reported. patient previously received first dose of bnt162b2 on an unspecified date for covid-19 immunization. It was reported that patient received second dose on 25th and after got the dose has been feeling really tired, sleepy and just weak in general. Patient wanted to know if there is anything can do or take to help with that and if not how long, how much longer will take this feeling like this and patient have been having this quite randomly. The outcome for the events was reported as unknown.   Information about lot/batch number has been requested.
Erythematous, blanching patches across chest, abdomen, and pelvis.  Treatment: Medrol dose pack.
Fever (101.8°F), Fever (100.2°F), chills, lightheaded, headache
achiness, soreness at site, appetite down, tired, H/A, coughing Temp 99.5
ash in left arm where they administered the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (ash in left arm where they administered the vaccine) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced VACCINATION SITE RASH (ash in left arm where they administered the vaccine). At the time of the report, VACCINATION SITE RASH (ash in left arm where they administered the vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No other relevant concomitant medication were reported. No treatment information were reported.
Fiver, intense muscle pain, black paint, burning, inflammation in the lymph glands and among other.
Large extremely swollen area on arm around injection site, black and blue discoloration in middle; area at 4"x3". Very hot to touch. Red and blotchy around perimeter. Very hard and skin stretched and leathery, started to split and weep clear liquid. Next morning area covered with blisters; black gone. Vaccine given 10/26 and peaked 10/27 night. Next 3 days fever and fussiness. Told by doctor on 10/27 that this happened to 3 or 4 other children the last 2 weeks. No sleep for 5 nights. He refused to eat for 4 days; fever returned on fifth and sixth day.
This spontaneous case reported by a consumer, describes the occurrence of nasal congestion (congestion in the nasal cavity/didn't have the drainage that I normally have) and vaccination site pain (bruise-type feeling) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 037K20A) for COVID-19 immunization. No medical history reported. On Jan 18, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Jan 20, 2021, patient experienced nasal congestion (congestion in the nasal cavity/didn't have the drainage that I normally have). On Jan 21, 2021, patient experienced vaccination site pain (bruise-type feeling). On Jan 22, 2021, vaccination site pain (bruise-type feeling): resolved. At the time of the report, nasal congestion (congestion in the nasal cavity/didn't have the drainage that I normally have) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medications or treatment information were provided. Reporter did not allow further contact.
No adverse reaction, vaccine was given on 10/22/21 and it was expired the day prior on 10/21/21
patient experienced headache; This is a spontaneous report received from a contactable nurse. A 88-year-old non-pregnant female patient received BNT162B2 (Solution for injection) via intramuscular route on an unknown date in Mar2021 (second dose) at an unknown dose, single for COVID-19 immunization. Relevant medical history included glaucoma. Historical vaccine included BNT162B2 in Mar2021 for Covid-19 immunization at the age of 88-years. The concomitant medications were not reported. Prior and since the vaccination, the patient was not diagnosed with COVID-19. On 24Mar2021, patient experienced headache. The outcome of the event was not resolved.  Information on the lot/batch number has been requested.
one day after covid/tdap vaccinations patient reported swelling of legs from below knee to ankle area and red/burnt looking.
My eyes, nose, throat, and ears started to itch and burn. My eyes swelled to the point that one eye was completely swollen shut. My lower lip started to swell slightly, but not much. I took Cetirizine Hydrocloride 10 mg. I took one pill in the morning and one in the evening until the evening of 1/25. The burning and itching subsided in an hour. The swelling in my eyes was not completely resolved until the morning of 1/26. 1/22 - 1/24, I was extremely fatigued, sleeping most of the time day and night. On 1/26, I felt that my symptoms had completely resolved.
Monovalent vaccine that incurred a temperature excursion on 26-SEP-2022 the temperature reached minus 14.8 degrees Celsius for 5 minutes; Patients received the Moderna Covid-19 vaccine after it had undergone a temperature excursion; Monovalent vaccine stored in freezer and temperature reached minus 14.8 degrees Celsius for 5 minutes; No adverse event; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Monovalent vaccine that incurred a temperature excursion on 26-SEP-2022 the temperature reached minus 14.8 degrees Celsius for 5 minutes), POOR QUALITY PRODUCT ADMINISTERED (Patients received the Moderna Covid-19 vaccine after it had undergone a temperature excursion), PRODUCT STORAGE ERROR (Monovalent vaccine stored in freezer and temperature reached minus 14.8 degrees Celsius for 5 minutes) and NO ADVERSE EVENT (No adverse event) in a 4-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Monovalent vaccine that incurred a temperature excursion on 26-SEP-2022 the temperature reached minus 14.8 degrees Celsius for 5 minutes), POOR QUALITY PRODUCT ADMINISTERED (Patients received the Moderna Covid-19 vaccine after it had undergone a temperature excursion), PRODUCT STORAGE ERROR (Monovalent vaccine stored in freezer and temperature reached minus 14.8 degrees Celsius for 5 minutes) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Monovalent vaccine that incurred a temperature excursion on 26-SEP-2022 the temperature reached minus 14.8 degrees Celsius for 5 minutes), POOR QUALITY PRODUCT ADMINISTERED (Patients received the Moderna Covid-19 vaccine after it had undergone a temperature excursion), PRODUCT STORAGE ERROR (Monovalent vaccine stored in freezer and temperature reached minus 14.8 degrees Celsius for 5 minutes) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Monovalent vaccine that incurred a temperature excursion on 26-SEP-2022 the temperature reached minus 14.8 degrees Celsius for 5 minutes), POOR QUALITY PRODUCT ADMINISTERED (Patients received the Moderna Covid-19 vaccine after it had undergone a temperature excursion) and PRODUCT STORAGE ERROR (Monovalent vaccine stored in freezer and temperature reached minus 14.8 degrees Celsius for 5 minutes).    It was reported that patient was pediatric patient. It was reported that temperature excursion occur on 26-SEP-2022. No concomitant information was reported. No treatment information was provided.   This case was linked to MOD-2022-661326 (Patient Link).
Erythematous rash started in left arm the next morning and spread to other arm, legs and trunk but not face. No fever or other symptoms. Rash still apparent at 13:30 on 12/26/00. Referred to Pediatric Clinic for evaluation and follow-up or ER prn.
Slowly developing hive that eventually covered most of my bicep. Got red, raised, hot and painful. Lasted a week or so. Took aspirin for the discomfort.
Days after receiving Tdap shot, redness, swelling and itching. Saw private Dr. He advised to put cold pack on area, take over the counter allergy med. at night Also gave a prescription to take should condition worsen. Condition appeared to get better, with redness becoming less. Total redness did not go away and area ached at times. Started the prescription of sulfameth/trimeth 800/160 mg two days later. Shot given 4-11-07 started Rx 4-16-07
Persistent atrial fibrillation. Hospital admission. This event was within 6 weeks of receiving the COVID vaccine.
GAVE PFIZER BOOSTER DOSE TO PATIENT THAT IS UNDER 18 YEARS OF AGE
pt recv vax 23JUL97 & devel 3 blisters on lt arm;it was reported that 23 other pt had similar exp WAES97080681;97091278-97091279
10.5 X 4.25 area left upper arm. Hard, red, hot and slightly painful . No fever
Patient admitted for other reason. Patient did receive anticoagulation with Lovenox 40 mg BID subQ.
Student fainted in chair after receiving vaccine. Transported by W/C to RN's office. Popsicle given, ice given. Rested x 30 min. Ret. to class.